- Accesswire•18 hours agoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline - NVO
NEW YORK, NY / ACCESSWIRE / February 24, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: ...
Safety concerns have re-emerged after a patient died in Roche’s hemophilia trial.
- Accesswire•2 days agoPawar Law Group Announces that a Securities Class Action Lawsuit has been filed Against Novo Nordisk A/S - NVO
NEW YORK, NY / ACCESSWIRE / February 23, 2017 / The Pawar Law Group announces a class action lawsuit on behalf of Novo Nordisk A/S. ("Novo Nordisk" or the "Company") (NYSE: NVO) investors ...
NVO : Summary for Novo Nordisk A/S - Yahoo Finance
Novo Nordisk A/S (NVO)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||33.10 x 100|
|Ask||36.01 x 200|
|Day's Range||35.42 - 35.63|
|52 Week Range||30.89 - 57.81|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.58|
|Dividend & Yield||1.12 (3.12%)|
|1y Target Est||N/A|